Mogy Joel R Investment Counsel Inc Abb Vie Inc. Transaction History

Mogy Joel R Investment Counsel Inc

$1.58 Billion
Q2 2024

A detailed history of Mogy Joel R Investment Counsel Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Mogy Joel R Investment Counsel Inc holds 52,361 shares of ABBV stock, worth $9.02 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares

52,361

Previous 52,361 -0.0%

Holding current value

$9.02 Million

Previous $9.53 Million 5.81%

% of portfolio

0.57%

Previous 0.65%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	SELL	$159.82 - $182.1 $31,964 - $36,420	-200 Reduced 0.38%	52,361 $9.53 Million
Q4 2023 Feb 02, 2024	SELL	$137.6 - $154.97 $280,704 - $316,138	-2,040 Reduced 3.74%	52,561 $8.15 Million
Q3 2023 Nov 01, 2023	SELL	$133.59 - $154.65 $1.12 Million - $1.3 Million	-8,375 Reduced 13.3%	54,601 $8.14 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $2,892 - $3,330	-20 Reduced 0.03%	62,976 $10 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $48,408 - $58,054	350 Added 0.56%	62,996 $10.2 Million

Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $2,818 - $3,232	-21 Reduced 0.03%	62,646 $8.41 Million
Q2 2022 Aug 12, 2022	BUY	$137.62 - $174.96 $2,890 - $3,674	21 Added 0.03%	62,667 $9.6 Million
Q1 2022 May 12, 2022	SELL	$131.98 - $163.75 $53,055 - $65,827	-402 Reduced 0.64%	62,646 $10.2 Million
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $6.1 Million - $7.71 Million	56,744 Added 900.13%	63,048 $8.54 Million
Q4 2021 Feb 10, 2022	SELL	$107.43 - $135.93 $6.09 Million - $7.71 Million	-56,724 Reduced 90.0%	6,304 $8.54 Million
Q2 2021 Aug 04, 2021	SELL	$105.21 - $117.21 $3,156 - $3,516	-30 Reduced 0.05%	63,028 $7.1 Million
Q4 2020 Feb 08, 2021	SELL	$80.49 - $108.67 $32,195 - $43,468	-400 Reduced 0.63%	63,058 $6.76 Million
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $25,773 - $30,249	-300 Reduced 0.47%	63,458 $5.56 Million
Q1 2020 May 08, 2020	SELL	$64.5 - $97.79 $19,350 - $29,337	-300 Reduced 0.47%	63,758 $4.86 Million
Q4 2019 Jan 29, 2020	SELL	$72.13 - $90.25 $721 - $902	-10 Reduced 0.02%	64,058 $5.67 Million
Q3 2019 Oct 31, 2019	SELL	$62.98 - $75.72 $3,149 - $3,786	-50 Reduced 0.08%	64,068 $4.85 Million
Q2 2019 Aug 08, 2019	SELL	$65.7 - $83.98 $12,023 - $15,368	-183 Reduced 0.28%	64,118 $4.66 Million
Q1 2019 Apr 30, 2019	SELL	$77.14 - $90.79 $505,652 - $595,128	-6,555 Reduced 9.25%	64,301 $5.18 Million
Q3 2018 Nov 05, 2018	SELL	$88.91 - $98.84 $177 - $197	-2 Reduced -0.0%	70,856 $6.7 Million
Q2 2018 Aug 03, 2018	SELL	$89.78 - $106.23 $2,244 - $2,655	-25 Reduced 0.04%	70,858 $6.57 Million
Q1 2018 May 02, 2018	SELL	$92.01 - $123.21 $46,005 - $61,605	-500 Reduced 0.7%	70,883 $6.71 Million
Q4 2017 Feb 07, 2018	SELL	$89.56 - $98.21 $58,930 - $64,622	-658 Reduced 0.91%	71,383 $6.9 Million
Q3 2017 Nov 09, 2017	BUY	$69.85 - $89.22 $5.03 Million - $6.43 Million	72,041	72,041 $6.4 Million

Others Institutions Holding ABBV

# of Institutions

3,650

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.5M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $305B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mogy Joel R Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mogy Joel R Investment Counsel Inc with notifications on news.

Account

Mogy Joel R Investment Counsel Inc Abb Vie Inc. Transaction History